Determinants of glycemic control in stable, insulin-treated type 2 diabetic veterans

被引：0
|
作者：
Bokhari, SU
Duckworth, WC
Shah, JH
Wendel, CS
Adam, KD
Hoffman, RM
Solvas, PA
Murata, GH
机构：
来源：
DIABETES | 2002年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2565
引用
收藏
页码：A618 / A618
页数：1
相关论文
共 50 条
  • [31] THE EFFECT OF EXENATIDE THERAPY IN PREVIOUSLY INSULIN-TREATED TYPE 2 DIABETIC PATIENTS
    Yasar, H. Y.
    Ceyhan, B. Ozturk
    Pamuk, B. O.
    Demirpence, M.
    Ertugrul, O.
    Ertugrul, D.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2017, 13 (04) : 447 - 453
  • [32] Are insulin-treated type 2 diabetic subjects at higher risk for foot ulcers?
    Ezio, F
    Fabrizio, F
    Antonella, Q
    Patrizia, C
    Alberto, M
    DIABETES CARE, 1999, 22 (08) : 1379 - 1380
  • [33] WHAT IS THE NUMBER OF SELF MONITORED BLOOD GLUCOSES NECESSARY TO MAINTAIN GLYCEMIC CONTROL IN STABLE INSULIN-TREATED TYPE-II DIABETICS
    MORALES, C
    FOX, E
    SHIPP, JC
    DIABETES, 1993, 42 : A184 - A184
  • [34] Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
    Mannucci, Edoardo
    Monami, Matteo
    Balzi, Daniela
    Cresci, Barbara
    Pala, Laura
    Melani, Cecilia
    Lamanna, Caterina
    Bracali, Ilaria
    Bigiarini, Michela
    Barchielli, Alessandro
    Marchionni, Niccolo
    Rotella, Carlo Maria
    DIABETES CARE, 2010, 33 (09) : 1997 - 2003
  • [35] Effect of metformin on fibrinolytic parameters in insulin-treated, type 2 diabetic patients
    Gin, H
    Roudaut, MF
    Vergnot, V
    Baillet, L
    Rigalleau, V
    DIABETES & METABOLISM, 2003, 29 (05) : 505 - 508
  • [36] Rosiglitazone (RSG) improves glycemic control in poorly controlled, insulin-treated type 2 diabetes (T2D)
    Raskin, P
    Dole, JF
    Rappaport, EB
    DIABETES, 1999, 48 : A94 - A94
  • [37] INSULIN ANTIBODY LEVELS DO NOT AFFECT GLYCEMIC CONTROL IN PATIENTS WITH INSULIN-TREATED DIABETES
    Molinari, C.
    Caretto, A.
    Bolla, A. M.
    Laurenzi, A.
    Bosi, E.
    Scavini, M.
    Dozio, N.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A109 - A110
  • [38] Effects of MK-0941, a Novel Glucokinase Activator, on Glycemic Control in Insulin-Treated Patients With Type 2 Diabetes
    Meininger, Gary E.
    Scott, Russell
    Alba, Maria
    Yue Shentu
    Luo, Edmund
    Amin, Himal
    Davies, Michael J.
    Kaufman, Keith D.
    Goldstein, Barry J.
    DIABETES CARE, 2011, 34 (12) : 2560 - 2566
  • [39] Determinants of Glycemic Control and Quality of Life In Type 2 Diabetic Patients
    Souza, Rodrigo A. P.
    Correr, Cassyano J.
    Melchiors, Ana C.
    Sanches, Andreia C. C.
    Wiens, Astrid
    Pontarolo, Roberto
    LATIN AMERICAN JOURNAL OF PHARMACY, 2011, 30 (05): : 860 - 867
  • [40] Impact of acute-phase insulin secretion on glycemic variability in insulin-treated patients with type 2 diabetes
    Si, Yiming
    Shen, Yun
    Lu, Jingyi
    Ma, Xiaojing
    Zhang, Lei
    Mo, Yifei
    Lu, Wei
    Zhu, Wei
    Bao, Yuqian
    Hu, Gang
    Zhou, Jian
    ENDOCRINE, 2020, 68 (01) : 116 - 123
12345